The colorectal cancer market is expected to grow from US$ 18,619.3 million in 2022 to US$ 24,078.5 million by 2028; it is expected to grow at a CAGR of 3.3% from 2022 to 2028.
Factors such as the increasing prevalence of colorectal cancer, product launches, and benefits offered by generic drugs are driving the global colorectal cancer market growth. However, pricing pressure on drug manufacturers is hindering the market growth.Colorectal cancer is a malignant tumor of the large intestine's inner wall. This is due to abnormal cell growth that can invade or spread to other body parts. Colorectal cancer is commonly caused by inflammatory bowel disease and genetic inheritance. Fatigue, diarrhea or constipation, shortness of breath, weakness, change in bowel habits, red or dark blood in stool, weight loss, abdominal pain, and bloating are a few common symptoms. Colorectal cancer is classified into four stages: stage 0, stage I-cancer in the inner layers of the colon, stage II-cancer spreads through the muscle wall of the colon, stage III-cancer spreads to lymph nodes, and stage IV-cancer spreads to other organs. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Colorectal Cancer Market: Strategic Insights
Market Size Value in US$ 18,619.3 Million in 2022 Market Size Value by US$ 24,078.5 Million by 2028 Growth rate CAGR of 3.3% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Colorectal Cancer Market: Strategic Insights
| Market Size Value in | US$ 18,619.3 Million in 2022 |
| Market Size Value by | US$ 24,078.5 Million by 2028 |
| Growth rate | CAGR of 3.3% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
North America is likely to dominate the colorectal cancer market during the forecast period owing to increasing incidences of colorectal cancer, better healthcare infrastructure, supportive government policies, a huge base of multinational companies, and high awareness among people about diagnostic testing and devices in healthcare. In addition, the US held the largest share of the North American market in 2022, and the country is expected to dominate the regional market during the forecast period. As per the American Cancer Society, colorectal cancer is the third most common cancer diagnosed in both men and women in the US, and ~104,270 new cases of colon cancer and 45,230 new cases of rectal cancer were reported in the country in 2021. The lifetime risk of getting diagnosed with colorectal cancer is ~1 in 22 for men, which accounts for ~5%. Similarly, for women, it is about 1 in 24, which accounts for ~4.5%. This rising number of cancer cases is augmenting the demand for colorectal cancer treatment and diagnostics across the country.
The global colorectal cancer market is segmented into modality, end user, and geography. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The global colorectal cancer market report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, market dynamics, and the competitive analysis of the globally leading market players.
Lucrative Regions for Global Colorectal Cancer Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rise in Incidence of Colorectal Cancer
Rise in Incidence of Colorectal Cancer
Colorectal cancer is one of the most commonly found and lethal cancers developed in individuals with the combined influence of genetic and environmental factors. According to the World Health Organization (WHO), colorectal cancer is the third most prevalent form of cancer, with ~1.93 million global cases in 2020, and an increase of ~70% in colorectal cancer cases worldwide is expected by 2030. Furthermore, according to the National Institute of Health, colorectal cancer (CRC) accounts for over 9% of all cancer incidences and is a major cause of morbidity and mortality worldwide in 2020. Furthermore, colorectal cancer mortality and incidence rates vary globally, and ~916,000 deaths in 2020 were due to colorectal cancer. It is the third most common cancer in men and the second most common cancer in women. The lifetime risk of developing colorectal cancer is about 1 in 23 for men and 1 in 25 for women. Therefore, colorectal cancer was identified as the third most common cancer and the second most death-causing cancer.
Colorectal cancer is increasingly affecting the populations in Asian countries. For instance, according to the International Agency for Research on Cancer & GLOBOCAN, the estimated incidence of colorectal cancer in Asia reported ~1,009,400 new cases in 2020. Japan, China, Malaysia, Singapore, Korea, and Turkey witnessed high prevalence rates compared to the other countries in Asia Pacific.
People with localized stage colorectal cancer have a 90% chance of surviving after five years. The 5-year survival rate is 71% if cancer spreads to neighboring tissues, organs, or regional lymph nodes. Surgery, immunotherapy, chemotherapy, radiation therapy, and targeted therapy are the most common treatment for colorectal cancer. Depending on the cancer stage, two or more of these treatment methods can be administered concurrently or sequentially.
Thus, the rising number of patients suffering from the disease has increased the demand for colorectal cancer solutions, thus driving the growth of the global colorectal cancer market.
Modality Insights
Based on modality, the global colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment holds the largest market share and is expected to register the highest CAGR during the forecast period. Moreover, the diagnosis type segment is further categorized into immunohistochemistry, stool test, flexible sigmoidoscopy, colonoscopy, CEA test, and others. The stool test segment is anticipated to register the highest CAGR in the market during the forecast period, owing to the increasing number of diagnostics tests done by patients.
Colorectal Cancer Market, by Modality – during 2022-2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End User Insights
Based on end user, the global colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment holds a larger market share, and is expected to register a higher CAGR in the market during the forecast period. Hospitals are the largest entities that have all the facilities. The hospital provides extensive healthcare and medical services to patients suffering from various diseases and disorders. Nowadays, hospitals give better services to their patients. Enormous patients are admitted for the procedure while several patients walk-in for the diagnostics. Among the admitted patients, most of them are already suffering from a few disorders. Thus, hospitals are contributing a significant market share to the global colorectal cancer market and are expected to continue the trend during the forecast period.
Several emergency and treatment centers need an investigation of the body's organs, tissues, and functions that can be done accurately with the help of magnetic resonance imaging, CT, and X-Ray. Most surgeries are being performed in hospitals, owing to continuous patient care and monitoring. As hospitals are primary healthcare centers for the people, it is likely to propel the growth of the end user segment over the forecast years. Therefore, owing to all the above-mentioned factors, the global colorectal cancer market for the hospital segment is likely to grow in the coming years.
Product launches and collaborations are highly adopted strategies by the global colorectal cancer market players to expand their global footprints and product portfolios. The players also focus on the partnership strategy to enlarge their clientele, allowing them to maintain their brand name globally. They aim to flourish their market shares with the development of innovative products. A few of the recent key market developments are listed below:
- In May 2022, Bruker launched an innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. Following the success of its BioSpec Maxwell 3 Tesla model, the new range of Maxwell 7 Tesla and 9.4 Tesla magnets eliminates the need for liquid Helium or Nitrogen refills while offering high-field sensitivity and resolution for advanced preclinical MRI and PET/MR research.
- In January 2022, Amgen and Generate Biomedicines entered a research collaboration agreement to discover and develop protein therapeutics for five clinical targets across multiple therapeutic areas and modalities. The collaboration will increase drug discovery efforts, generating novel protein sequences with optimal therapeutic properties.
F. Hoffmann-La Roche AG, Epigenomics AG, Novigenix SA, Abbott Laboratories, Amgen Inc., Volitionrx, EDP Biotech, Clinical Genomics Technologies Pvt Ltd, Bruker, and Quest Diagnostics Incorporated are offering products and services in the market.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Modality, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Colorectal cancer is also known as bowel cancer, colon cancer, or rectal cancer. This type of cancer is the second leading cause of death in women and third in men. Colorectal cancer may be benign, or non-cancerous, or malignant. The symptoms shown by the patients who have colon cancer include changes in bowel habits, diarrhea or constipation, blood in stools that make it look black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.
The factors that are driving the growth of market are rising prevalence of colorectal cancer, new product launches, and benefits offered by generic drugs boost the market growth. However, pricing pressure on drug manufacturers is the major factor hindering the colorectal cancer market growth.
The colorectal cancer market majorly consists of the players, such as Epigenomics AG, Novigenix SA, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Volitionrx Limited, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche AG, Bruker Corporation, Quest Diagnostics Incorporated among others.
The market is estimated to grow at a CAGR of 3.3% during the forecast period.
The colorectal cancer market is estimated to be valued at US$ 18,619.3 million in 2022.
The colorectal cancer market is expected to be valued at US$ 24,078.5 million in 2028.
The colorectal cancer market is analyzed in the basis of modality and end user. Based on modality, the market is segmented into diagnosis type, therapy type, and imaging type. The diagnosis type segment held the largest share of the market. Moreover, the same segment is anticipated to register the highest CAGR in the forecast period.
North America accounts for the major market share of colorectal cancer market in 2022 due to the increasing prevalence of colorectal cancer cases in the region and increased awareness about the disease.
Asia Pacific is expected to be the fastest growing region in colorectal cancer market over the forecast period due to developing healthcare infrastructure, enormous population base, growing prevalence of colorectal cancer patients, increased knowledge of the disease, growing government efforts, and technological improvement in the sector.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Colorectal Cancer Market – By Modality
1.3.2 Global Colorectal Cancer Market – By End User
1.3.3 Global Colorectal Cancer Market – By Geography
2. Global Colorectal Cancer Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Colorectal Cancer– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Colorectal Cancer Market - North America PEST Analysis
4.2.2 Colorectal Cancer Market - Europe PEST Analysis
4.2.3 Colorectal Cancer Market – Asia Pacific PEST Analysis
4.2.4 Colorectal Cancer Market – Middle East & Africa PEST Analysis
4.2.5 Colorectal Cancer Market – South And Central America PEST Analysis
4.3 Expert Opinion
5. Global Colorectal Cancer Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 New Product Launches
5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Market Opportunities
5.3.1 Growing Pharmaceutical Industry in Emerging Economies
5.4 Future Trends
5.4.1 Inclination Toward Personalized Medicine
5.5 Impact Analysis
6. Global Colorectal Cancer Market– Global Analysis
6.1 Global Colorectal Cancer Market Revenue Forecast and Analysis
6.1.1 Overview
6.1.2 Global Colorectal Cancer Market, By Geography - Forecasts And Analysis
6.1.3 Global Colorectal Cancer Market– Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Share Analysis of Key Players in Global Colorectal Cancer Market (2021)
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Abbott
6.2.4.2 F. Hoffmann-La Roche AG
7. Global Colorectal Cancer Market Analysis – By Modality
7.1 Overview
7.2 Global Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
7.3.1 Overview
7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Immunohistochemistry
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Stool Test
7.3.4.1 Overview
7.3.4.2 Stool Test : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Flexible Sigmoidoscopy
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Colonoscopy
7.3.6.1 Overview
7.3.6.2 Colonoscopy : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 CEA Test
7.3.7.1 Overview
7.3.7.2 CEA Test : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Test
7.3.8.1 Overview
7.3.8.2 Other Test : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
7.4.1 Overview
7.4.2 Global Therapy Type : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemotherapy
7.4.3.1 Overview
7.4.3.2 Chemotherapy : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.3 Alkylating Agent
7.4.3.3.1 Overview
7.4.3.3.2 Alkylating Agent : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.4 Antimetabolites
7.4.3.4.1 Antimetabolites : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.5 Others
7.4.3.5.1 Others : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Immunotherapy
7.4.4.1 Overview
7.4.4.2 Immunotherapy : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.3 Panitumumab
7.4.4.3.1 Overview
7.4.4.3.2 Panitumumab : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.4 Cetuximab
7.4.4.4.1 Overview
7.4.4.4.2 Cetuximab : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.5 Bevacizumab
7.4.4.5.1 Overview
7.4.4.5.2 Bevacizumab : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.6 Others
7.4.4.6.1 Overview
7.4.4.6.2 Others : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Chemoprotectant
7.4.5.1 Overview
7.4.5.2 Chemoprotectant : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
7.5.1 Overview
7.5.2 Global Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Computed Tomography (CT)
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Magnetic Resonance Imaging (MRI)
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI) : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others
7.5.5.1 Overview
7.5.5.2 Others : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Colorectal Cancer Market Revenue and Forecast To 2028 – By End User
8.1 Overview
8.2 Global Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
8.4.1 Overview
8.4.2 Diagnostic and Research Laboratories : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Colorectal Cancer Market Revenue and Forecast to 2028 – Geographical Analysis
9.1 North America: Colorectal Cancer Market
9.1.1 Overview
9.1.2 North America: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.3.1 North America: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.3.2 North America: Colorectal Cancer Market, by Therapy Type – 2019–2028 (US$ Million)
9.1.3.2.1 North America: Colorectal Cancer Market, by Chemotherapy– 2019–2028 (US$ Million)
9.1.3.2.2 North America: Colorectal Cancer Market, by Immunotherapy– 2019–2028 (US$ Million)
9.1.3.3 North America: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.4 North America: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.5 North America: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
9.1.5.1 US: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 US: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 US: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.5.1.2.1 US: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.5.1.2.2 US: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.1.5.1.2.2.1. US: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)
9.1.5.1.2.2.2. US: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.5.1.2.3 US: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.5.1.3 US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.5.2 Canada: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Canada: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 Canada: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.5.2.2.1 Canada: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
1.1.5.2.1.1 Canada: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.5.2.2.1.1. Canada: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)
9.1.5.2.2.1.2. Canada: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.5.2.2.2 Canada: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.5.2.3 Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.5.3 Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Mexico: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.5.3.2.1 Mexico: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.1.5.3.2.2 Mexico: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.1.5.3.2.2.1. Mexico: Colorectal Cancer Market, by Chemotherapy– 2019-2028 (US$ Million)
9.1.5.3.2.2.2. Mexico: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.1.5.3.2.3 Mexico: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.1.5.3.3 Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
9.2 Europe: Colorectal Cancer Market
9.2.1 Overview
9.2.2 Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.2.3.1 Europe: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.2.3.2 Europe: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.2.3.2.1 Europe: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.2.3.2.2 Europe: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.2.3.3 Europe: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.2.4 Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.2.5 Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
9.2.5.1 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.2 Germany: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.2.5.1.2.1 Germany: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.2.5.1.2.2 Germany: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.2.5.1.2.2.1. Germany: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.2.5.1.2.2.2. Germany: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.2.5.1.2.3 Germany: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.2.5.1.3 Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.2.5.2 France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.2 France: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.2.5.2.2.1 France: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.2.5.2.2.2 France: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.2.5.2.2.2.1. France: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.2.5.2.2.2.2. France: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.2.5.2.2.3 France: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.2.5.2.3 France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.2.5.3 UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.2 UK: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.2.5.3.2.1 UK: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.2.5.3.2.2 UK: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.2.5.3.2.2.1. UK: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.2.5.3.2.2.2. UK: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.2.5.3.2.3 UK: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.2.5.3.3 UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.2.5.4 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.2 Italy: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.2.5.4.2.1 Italy: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.2.5.4.2.2 Italy: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.2.5.4.2.2.1. Italy: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.2.5.4.2.2.2. Italy: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.2.5.4.2.3 Italy: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.2.5.4.3 Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.2.5.5 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.2 Spain: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.2.5.5.2.1 Spain: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.2.5.5.2.2 Spain: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.2.5.5.2.2.1. Spain: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.2.5.5.2.2.2. Spain: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.2.5.5.2.3 Spain: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.2.5.5.3 Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.2.5.6 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.2 Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.2.5.6.2.1 Rest of Europe: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.2.5.6.2.2 Rest of Europe: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.2.5.6.2.2.1. Rest of Europe: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.2.5.6.2.2.2. Rest of Europe: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.2.5.6.2.3 Rest of Europe: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.3 Asia Pacific Colorectal Cancer Market Revenue and Forecast to 2028
9.3.1 Overview
9.3.2 Asia Pacific: Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.3 Asia Pacific: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.3.3.1 Asia Pacific: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.3.3.2 Asia Pacific Therapy Type Market Revenue and Forecasts to 2028, By Therapy Type (US$ Million)
9.3.3.2.1 Asia Pacific Chemotherapy Market Revenue and Forecasts to 2028, By Chemotherapy (US$ Million)
9.3.3.2.2 Asia Pacific Immunotherapy Market Revenue and Forecasts to 2028, By Immunotherapy (US$ Million)
9.3.3.3 Asia Pacific Imaging Type Market Revenue and Forecasts to 2028, By Imaging Type (US$ Million)
9.3.4 Asia Pacific : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.3.5 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
9.3.5.1 China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.1.1 China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.1.2 China: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.3.5.1.2.1 China: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.3.5.1.2.2 China: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.3.5.1.2.2.1. China: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.3.5.1.2.2.2. China: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.3.5.1.2.3 China: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.3.5.1.3 China : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.3.5.2 Japan Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.2.1 Japan Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.2.2 Japan: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.3.5.2.2.1 Japan: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.3.5.2.2.2 Japan: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.3.5.2.2.2.1. Japan: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.3.5.2.2.2.2. Japan: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.3.5.2.2.3 Japan: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.3.5.2.3 Japan : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.3.5.3 India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.3.1 India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.3.2 India: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.3.5.3.2.1 India: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.3.5.3.2.2 India: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.3.5.3.2.2.1. India: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.3.5.3.2.2.2. India: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.3.5.3.2.3 India: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.3.5.3.3 India : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.3.5.4 South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.4.1 South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.4.2 South Korea: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.3.5.4.2.1 South Korea: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.3.5.4.2.2 South Korea: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.3.5.4.2.2.1. South Korea: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.3.5.4.2.2.2. South Korea: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.3.5.4.2.3 South Korea: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.3.5.4.3 South Korea : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.3.5.5 Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.5.1 Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.3.5.5.2 Australia: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.3.5.5.2.1 Australia: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.3.5.5.2.2 Australia: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.3.5.5.2.2.1. Australia: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.3.5.5.2.2.2. Australia: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.3.5.5.2.3 Australia: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.3.5.5.3 Australia : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.3.5.6 Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia Pacific:: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.3.5.6.3.1 Rest of Asia Pacific:: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.3.5.6.3.2 Rest of Asia Pacific:: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.3.5.6.3.2.1. Rest of Asia Pacific:: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.3.5.6.3.2.2. Rest of Asia Pacific:: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.3.5.6.3.3 Rest of Asia Pacific:: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.3.5.6.4 Rest of Asia Pacific: : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.4 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2028
9.4.1 Overview
9.4.2 Middle East & Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.4.3 Middle East & Africa: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.4.3.1 Middle East & Africa: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.4.3.2 Middle East & Africa: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.4.3.2.1 Middle East & Africa: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.4.3.2.2 Middle East & Africa: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.4.3.3 Middle East & Africa: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.4.4 Middle East & Africa : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.4.5 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
9.4.5.1 UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.4.5.1.1 UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.4.5.1.2 UAE: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.4.5.1.2.1 UAE: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.4.5.1.2.2 UAE: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.4.5.1.2.2.1. UAE: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.4.5.1.2.2.2. UAE: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.4.5.1.2.3 UAE: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.4.5.1.3 UAE : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.4.5.2 Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.4.5.2.1 Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.4.5.2.2 Saudi Arabia: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.4.5.2.2.1 Saudi Arabia: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.4.5.2.2.2 Saudi Arabia: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.4.5.2.2.2.1. Saudi Arabia: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.4.5.2.2.2.2. Saudi Arabia: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.4.5.2.2.3 Saudi Arabia: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.4.5.2.3 Saudi Arabia : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.4.5.3 South Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.4.5.3.1 South Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
9.4.5.3.2 South Africa: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.4.5.3.2.1 South Africa: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.4.5.3.2.2 South Africa: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.4.5.3.2.2.1. South Africa: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.4.5.3.2.2.2. South Africa: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.4.5.3.2.3 South Africa: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.4.5.3.3 South Africa : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.4.5.4 Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East and Africa:: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.4.5.4.3.1 Rest of Middle East and Africa:: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.4.5.4.3.2 Rest of Middle East and Africa:: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
9.4.5.4.3.2.1. Rest of Middle East and Africa:: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.4.5.4.3.2.2. Rest of Middle East and Africa:: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.4.5.4.3.3 Rest of Middle East and Africa:: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
9.4.5.4.4 Rest of Middle East and Africa: : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.5 South and Central America: Colorectal Cancer Market
9.5.1 Overview
9.5.2 South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.3 South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.5.3.1 South and Central America: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.5.3.2 South and Central America: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.5.3.2.1 South and Central America: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.5.3.2.2 South and Central America: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.5.3.3 South and Central America: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.5.4 South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028, By End User (US$ Million)
9.5.5 South and Central America: Colorectal Cancer Market Share, by Country (2022 & 2028) (%)
9.5.5.1 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.1 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.2 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.5.5.1.2.1 Brazil: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.5.5.1.2.2 Brazil: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.5.5.1.2.2.1. Brazil: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.5.5.1.2.2.2. Brazil: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.5.5.1.2.3 Brazil: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.5.5.1.3 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)
9.5.5.2 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.1 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.2 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.5.5.2.2.1 Argentina: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.5.5.2.2.2 Argentina: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.5.5.2.2.2.1. Argentina: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.5.5.2.2.2.2. Argentina: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.5.5.2.2.3 Argentina: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.5.5.2.3 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)
9.5.5.3 Rest of South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.1 Rest of South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.2 Rest of South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
9.5.5.3.2.1 Rest of South and Central America: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
9.5.5.3.2.2 Rest of South and Central America: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)
9.5.5.3.2.2.1. Rest of South and Central America: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
9.5.5.3.2.2.2. Rest of South and Central America: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
9.5.5.3.2.3 Rest of South and Central America: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)
9.5.5.3.3 Rest of South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)
10. Impact of COVID-19 Pandemic on Geographic Regions
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Global Colorectal Cancer Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028
12. Company Profiles
12.1 Epigenomics AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novigenix SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Clinical Genomics Technologies Pty. Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Amgen Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. HOFFMANN-LA ROCHE LTD.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bruker Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Quest Diagnostics Incorporated
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 EDP Biotech Corporation
12.9.1 Business Description
12.9.2 Products and Services
12.9.3 Financial Overview
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.10 Volitionrx Limited
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 2. North America: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America: Colorectal Cancer Market, by Chemotherapy– – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)
Table 6. North America: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. North America: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 8. US: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 9. US: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. US: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. US: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 12. US: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)
Table 13. US: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 15. Canada: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 16. Canada: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Canada: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 19. Canada: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)
Table 20. Canada: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 22. Mexico: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 23. Mexico: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 25. Mexico: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 26. Mexico: Colorectal Cancer Market, by Immunotherapy– Revenue and Forecast To 2028 (US$ Million)
Table 27. Mexico: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
Table 29. Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 30. Europe: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 31. Europe: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Europe: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 33. Europe: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 34. Europe: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 36. Germany: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 37. Germany: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Germany: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 39. Germany: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 40. Germany: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 41. Germany: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 43. France: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 44. France: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 45. France: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 46. France: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 47. France: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 48. France: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 49. France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 50. UK: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 51. UK: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. UK: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. UK: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 54. UK: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 55. UK: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 57. Italy: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 58. Italy: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 59. Italy: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 60. Italy: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 61. Italy: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 62. Italy: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 63. Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 64. Spain: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 65. Spain: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 66. Spain: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 67. Spain: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 68. Spain: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 69. Spain: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 70. Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 71. Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 72. Rest of Europe: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Europe: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of Europe: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 75. Rest of Europe: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of Europe: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 77. Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 78. Asia Pacific: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 79. Asia Pacific Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 80. Asia Pacific Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 81. Asia Pacific Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 82. Asia Pacific Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 83. Asia Pacific Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 84. Asia Pacific: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 85. China Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 86. China Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 87. China Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 88. China Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 89. China Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 90. China Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 91. China: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 92. Japan Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 93. Japan Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 94. Japan Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 95. Japan Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 96. Japan Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 97. Japan Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 98. Japan: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 99. India Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 100. India Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 101. India Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 102. India Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 103. India Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 104. India Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 105. India: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 106. South Korea Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 107. South Korea Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 108. South Korea Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 109. South Korea Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 110. South Korea Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 111. South Korea Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 112. South Korea: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 113. Australia Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 114. Australia Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 115. Australia Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 116. Australia Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 117. Australia Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 118. Australia Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 119. Australia: Colorectal Cancer Market Revenue and Forecast to 2028, By End Users (US$ Million)
Table 120. Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million)
Table 121. Rest of Asia Pacific: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 122. Rest of Asia Pacific: Therapy Type Market Revenue and Forecasts To 2028, By Type (US$ Million)
Table 123. Rest of Asia Pacific: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 124. Rest of Asia Pacific: Colorectal Cancer Market, byImmunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 125. Rest of Asia Pacific: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 126. Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million)
Table 127. Middle East and Africa Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 128. Middle East and Africa Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 129. Middle East and Africa Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 130. Middle East and Africa Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 131. Middle East and Africa Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 132. Middle East and Africa Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 133. Middle East and Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 134. UAE Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 135. UAE Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 136. UAE Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 137. UAE Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 138. UAE Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 139. UAE Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 140. UAE: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 141. Saudi Arabia Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 142. Saudi Arabia Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 143. Saudi Arabia Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 144. Saudi Arabia Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 145. Saudi Arabia Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 146. Saudi Arabia Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 147. Saudi Arabia: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 148. South Africa Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 149. South Africa Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 150. South Africa Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 151. South Africa Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 152. South Africa Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 153. South Africa Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 154. South Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 155. Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million)
Table 156. Rest of Middle East and Africa: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 157. Rest of Middle East and Africa: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 158. Rest of Middle East and Africa: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 159. Rest of Middle East and Africa: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 160. Rest of Middle East and Africa: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 161. Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million)
Table 162. South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 163. South and Central America: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 164. South and Central America: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 165. South and Central America: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 166. South and Central America: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 167. South and Central America: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 168. South and Central America Colorectal Cancer Market – Revenue and Forecast to 2028, By End User (US$ Million)
Table 169. South and Central America Colorectal Cancer Market Share, by Country (2022 & 2028) (%)
Table 170. Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 171. Brazil: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 172. Brazil: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 173. Brazil: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 174. Brazil: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 175. Brazil: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 176. Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By End User (US$ Million)
Table 177. Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 178. Argentina: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 179. Argentina: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 180. Argentina: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 181. Argentina: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 182. Argentina: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 183. Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)
Table 184. Rest of South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
Table 185. Rest of South and Central America: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
Table 186. Rest of South and Central America: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
Table 187. Rest of South and Central America: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 188. Rest of South and Central America: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
Table 189. Rest of South and Central America: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
Table 190. Rest of South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)
Table 191. Recent Organic Growth Strategies In The Colorectal Cancer Market
Table 192. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
Table 193. Glossary of Terms, Colorectal Cancer Market
LIST OF FIGURES
Figure 1. Colorectal Cancer Market Segmentation
Figure 2. Colorectal Cancer Segmentation, By Region
Figure 3. Global Colorectal Cancer Market Overview
Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Colorectal Cancer Market, By Geography (US$ Million)
Figure 7. Global Colorectal Cancer Market- Leading Country Markets (US$ Million)
Figure 8. Global Colorectal Cancer Market, Industry Landscape
Figure 9. Colorectal Cancer Market - North America PEST Analysis
Figure 10. Colorectal Cancer Market - Europe PEST Analysis
Figure 11. Colorectal Cancer Market – Asia Pacific PEST Analysis
Figure 12. Colorectal Cancer Market – Middle East & Africa PEST Analysis
Figure 13. Colorectal Cancer Market – South and Central America PEST Analysis
Figure 14. Comparison of BrandED Drugs and Generic Drugs
Figure 15. Global Colorectal Cancer Market Impact Analysis of Drivers And Restraints
Figure 16. Global Colorectal Cancer Market – Revenue Forecasts And Analysis – 2020- 2028
Figure 17. Global Colorectal Cancer Market – By Geography Forecasts And Analysis – 2022- 2028
Figure 18. Global Colorectal Cancer Market – Market Potential Analysis, By Region
Figure 19. Market Positioning Of Key Player In Global Colorectal Cancer Market
Figure 20. Global Colorectal cancer Market – Comparative Company Analysis
Figure 21. Global Colorectal cancer market – Growth Strategy Analysis
Figure 22. Global Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 23. Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Global Therapy Type : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Global Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Global Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)
Figure 47. Hospitals: : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Diagnostic and Research Laboratories : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. North America: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)
Figure 50. North America: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
Figure 51. North America: Colorectal Cancer Market, By Country, 2022 & 2028 (%)
Figure 52. US: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
Figure 53. Canada: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
Figure 54. Mexico: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
Figure 55. Europe: Colorectal Cancer Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)
Figure 56. Europe Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
Figure 57. Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
Figure 58. Germany: Colorectal Cancer Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. France: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. UK: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Italy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Spain: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of Europe: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Asia Pacific: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)
Figure 65. Asia Pacific: Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 66. Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
Figure 67. China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 68. Japan Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 69. India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 70. South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 71. Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 72. Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
Figure 73. Middle East & Africa: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)
Figure 74. Middle East & Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 75. Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
Figure 76. UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 77. Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 78. South Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
Figure 79. Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
Figure 80. South and Central America Colorectal Cancer Market Overview, by Country (2022)
Figure 81. South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 82. Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 83. Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 84. Rest of South and Central America: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 85. Impact of COVID-19 Pandemic on North American Country Markets
Figure 86. Impact of COVID-19 Pandemic on European Country Markets
Figure 87. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 88. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 89. Impact of COVID-19 Pandemic on South & Central America Country Markets
Figure 90. Growth Strategies In The Colorectal Cancer Market, 2022-2028
The List of Companies - Colorectal Cancer Market
- Amgen Inc.
- Bruker Corporation
- Epigenomics AG
- Clinical Genomics Technologies Pty Ltd.
- VolitionRx Limited
- Novigenix SA
- F. Hoffmann-La Roche AG
- Abbott
- EDP Biotech
- Quest Diagnostics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Colorectal Cancer Market
Jun 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)